Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation products for the treatment of serious diseases, including cancer, using its proprietary platform.
Ticker code: CU6
Sector: Healthcare | Industry: Biotechnology | Website: https://www.claritypharmaceuticals.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $1,160,733,779 | $1,076,615,427 | 372030071.0 | 62.45 | $724,831,790 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $104,540,445 | $84,118,352 | $0 | -64.1 | None | -80.5 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 31.6 | $4,187,505 | $8,491,972 | 4.93 | 6.7 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | 100.0 | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $3.120 | -2.8 | 2.6 | -28.9 | -1.6 | 38.7 | -43.2 |
CU6 Price Chart with Volume and 3EMA
CU6 Short Positions
Click HERE to understand why the above moving averages have been chosen.